Aggressive NK-cell leukemia

From WikiMD's Medical Encyclopedia

(Redirected from ANKL)


Aggressive NK-cell leukemia
Natural killer cell
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Fever, weight loss, night sweats, hepatosplenomegaly, lymphadenopathy
Complications Hemophagocytic lymphohistiocytosis, multi-organ failure
Onset Typically in young adults
Duration Acute
Types N/A
Causes Genetic mutations, Epstein-Barr virus
Risks Immunosuppression, Asian descent
Diagnosis Blood test, bone marrow biopsy, immunophenotyping
Differential diagnosis T-cell leukemia, B-cell lymphoma, infectious mononucleosis
Prevention N/A
Treatment Chemotherapy, hematopoietic stem cell transplantation
Medication N/A
Prognosis Poor
Frequency Rare
Deaths N/A


Aggressive NK-cell leukemia
ICD-10
ICD-9
DiseasesDB
MedlinePlus
eMedicine
MeSH ID

Aggressive NK-cell leukemia is a rare and rapidly progressing form of leukemia characterized by the proliferation of natural killer cells. It is considered a subtype of large granular lymphocyte leukemia.

Signs and Symptoms[edit]

Patients with aggressive NK-cell leukemia often present with systemic symptoms such as fever, weight loss, night sweats, and fatigue. Other symptoms may include hepatosplenomegaly and lymphadenopathy.

Complications[edit]

This condition can lead to severe complications, including hemophagocytic lymphohistiocytosis (HLH), a life-threatening condition characterized by excessive immune activation and organ failure.

Causes[edit]

The exact cause of aggressive NK-cell leukemia is not well understood, but it is often associated with genetic mutations and viral infections, particularly the Epstein-Barr virus (EBV).

Diagnosis[edit]

Diagnosis typically involves a combination of blood tests, bone marrow biopsy, and immunophenotyping to identify the abnormal NK cells. Cytogenetic analysis may also be performed to detect specific genetic abnormalities.

Treatment[edit]

Treatment options are limited and often include chemotherapy and stem cell transplant. The prognosis for aggressive NK-cell leukemia is generally poor, with a high rate of relapse and resistance to treatment.

Epidemiology[edit]

Aggressive NK-cell leukemia is a rare disease, with a higher prevalence in East Asia. It affects both children and adults, with a slight male predominance.

See Also[edit]

References[edit]

<references/>

External Links[edit]




Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.